Human growth hormone (HGH) therapy can help increase muscle mass, improve body composition, and boost energy in those experiencing low growth hormone levels due to underlying health conditions. HGH ...

Novo Nordisk’s Sogroya is now approved for children aged 2.5 or older with idiopathic short stature, small for gestational age, and Noonan Syndrome.

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other ...

Growth hormone helps children grow in height and supports healthy metabolism. When a child does not have enough of this hormone, their growth may be slow. This is sometimes called growth failure.

Pediatric growth hormone deficiency (PGHD) is a genetic condition that affects your child’s physical development. Hormone replacement therapy can help promote growth, and a new injection now makes it ...

The primary sign of growth hormone deficiency in children is short stature. Adults may have decreased muscle mass and increased body fat, as well as other problems such as heart disease and depression ...

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya (R) (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...

Growth hormone, produced by the pituitary gland, plays a critical role in cell regeneration, growth, and maintaining healthy body tissue, including the brain and vital organs. While synthetic human ...